Frankfurt - Delayed Quote • EUR ABIVAX Société Anonyme (2X10.F) Follow Compare 5.55 +0.05 +(0.91%) At close: 8:16:34 AM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 2X10.F 1D 5D -15.91% 1M -13.95% 3M -41.27% 6M -47.64% YTD -13.95% 1Y -53.75% 5Y -34.32% All -34.32% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 2X10.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Abivax Publishes 2025 Financial Calendar Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Abivax Announces a Change to the Composition of its Board of Directors Why ABIVAX Société Anonyme (ABVX) is the Best All-Time Low Stock to Buy Right Now? Abivax Establishes an At-the-Market (ATM) Program on Nasdaq Abivax presents third quarter 2024 key financial information Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance Related Tickers BX2.F BioXcel Therapeutics, Inc. 0.3289 +10.00% W2J.F Carisma Therapeutics, Inc. 0.5940 0.00% YAG2.F Atossa Therapeutics, Inc. 0.8510 +21.57% PSH.F Sernova Corp. 0.1363 +0.22% W1H.F Onco-Innovations Limited 1.3300 +2.31% IFRX InflaRx N.V. 2.4100 +1.69% PPCB Propanc Biopharma, Inc. 9.00 0.00%